Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-κB expression

Brain Research

Volumn 1268, Issue , 2009, Pages 174-180

  Liu, Ying ^a   Zhang, Xiang jian ^a   Yang, Chen hui ^a   Fan, Hong guang ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral infarction; Middle cerebral artery; NF B; Oxymatrine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYMATRINE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALKALOIDS; ANIMALS; BODY WATER; BRAIN; BRAIN EDEMA; CELL NUCLEUS; CYTOPLASM; DOWN-REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; QUINOLIZINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

RATTUS;

EID: 64149117795     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.02.069     Document Type: Article

References (25)

1. Clemens J.A., Stephenson D.T., Yin T., Smalstig E.B., Panetta J.A., and Little S.P. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappa B in rats. Stroke 29 (1998) 677-682
2. Clemens J.A., Stephenson D.T., Dixon E.P., Smalstig E.B., Mincy R.E., Rash K.S., and Little S.P. Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res. Mol. Brain Res. 48 (1997) 187-196
3. Ding Y., Li J., Rafols J.A., Phillis J.W., and Diaz F.G. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats. Stroke 33 (2002) 2492-2498
4. Duckworth E.A., Butler T., Collier L., Collier S., and Pennypacker K.R. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res. 1088 (2006) 167-175
5. Gabriel C., Justicia C., Camins A., and Planas A.M. Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia. Brain Res. Mol. Brain Res. 65 (1999) 61-69
6. Hill W.D., Hess D.C., Carroll J.E., Wakade C.G., Howard E.F., Chen Q., Cheng C., Martin-Studdard A., Waller J.L., and Beswick R.A. The NF-kappa B inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Res. Bull. 55 (2001) 375-386
7. Hong-Li S., Lei L., Lei S., Dan Z., De-Li D., Guo-Fen Q., Yan L., Wen-Feng C., and Bao-Feng Y. Cardioprotective effects and underlying mechanisms of oxymatrine against ischemic myocardial injuries of rats. Phytother. Res. 22 (2008) 985-989
8. Jiang H., Meng F., Li J., and Sun X. Anti-apoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats. World J. Surg. 29 (2005) 1397-1401
9. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 20 (1989) 84-91
10. Małek R., Borowicz K.K., Jargiełło M., and Czuczwar S.J. Role of NF-κB in the central nervous system. Pharmacol. Rep. 59 (2007) 25-33
11. Mao Y.M., et al. Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study. World J. Gastroenterol. 10 (2004) 3269-3673
12. Nurmi A., Lindsberg P.J., Koistinaho M., Zhang W., Juettler E., Karjalainen-Lindsberg M.L., Weih F., Frank N., Schwaninger M., and Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35 (2004) 987-991
13. Nurmi A., Vartiainen N., Pihlaja R., Goldsteins G., Yrjänheikki J., and Koistinaho J. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J. Neurochem. 91 (2004) 755-765
14. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5 (1999) 554-559
15. Shen W.H., Zhang C.Y., and Zhang G.Y. Antioxidants attenuate reperfusion injury after global brain ischemia through inhibiting nuclear factor-kappa B activity in rats. Acta Pharmacol. Sin. 24 (2003) 1125-1130
16. Sironi L., Banfi C., Brioschi M., Gelosa P., Guerrini U., Nobili E., Gianella A., Paoletti R., Tremoli E., and Cimino M. Activation of NF-κB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment. Neurobiol. Dis. 22 (2006) 445-451
17. Tatlisumak T., Carano R.A., Takano K., Opgenorth T.J., Sotak C.H., and Fisher M. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke 29 (1998) 850-857 (discussion 857-8)
18. Terai K., Matsuo A., McGeer E.G., and McGeer P.L. Enhancement of immunoreactivity for NF-κB in human cerebral infarctions. Brain Res. 739 (1996) 343-349
19. Ueno T., Sawa Y., Kitagawa-Sakakida S., Nishimura M., Morishita R., Kaneda Y., Kohmura E., Yoshimine T., and Matsuda H. Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest. J. Thorac. Cardiovasc. Surg. 122 (2001) 720-727
20. Xu L., Zhan Y., Wang Y., Feuerstein G.Z., and Wang X. Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury. Biochem. Biophys. Res. Commun. 299 (2002) 14-17
21. Yi J.H., Park S.W., Kapadia R., and Vemuganti R. Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem. Int. 50 (2007) 1014-1027
22. Zhang H.L., Gu Z.L., Savitz S.I., Han F., Fukunaga K., and Qin Z.H. Neuroprotective effects of prostaglandinA(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation. J. Neurosci. Res. 86 (2008) 1132-1141
23. Zhao J., Yu S., Tong L., Zhang F., Jiang X., Pan S., Jiang H., and Sun X. Oxymatrine attenuates intestinal ischemia/reperfusion injury in rats. Surg. Today 38 (2008) 931-937
24. Zheng Z., and Yenari M.A. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol. Res. 26 (2004) 884-892
25. Zheng P., Niu F.L., Liu W.Z., Shi Y., and Lu L.G. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats. World J. Gastroenterol. 11 (2005) 4912-4915